Ifat Geron
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Diabetes and associated disorders
Papers in
- Hematology 13
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 6
- Surgery 7
- Pancreatic function and diabetes 6
- Co-authors
- Pamela Itkin‐Ansari (5 shared papers)Ergeng Hao (4 shared papers)Fred Levine (5 shared papers)Catriona Jamieson (11 shared papers)Annelie Abrahamsson (9 shared papers)Björn Tyrberg (3 shared papers)Mark Mercola (2 shared papers)Jeffrey A. Durocher (6 shared papers)
- Journals
- Blood (8 papers)Cancer Cell (2 papers)Nature Medicine (1 paper)Developmental Dynamics (1 paper)SLAS DISCOVERY (1 paper)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Ifat Geron
25 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 67
- Hematology 230
- Genetics 150
- Endocrinology, Diabetes and Metabolism 186
- Cancer Research 146
- Molecular Biology 591
Countries citing papers authored by Ifat Geron
This map shows the geographic impact of Ifat Geron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ifat Geron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ifat Geron more than expected).
Fields of papers citing papers by Ifat Geron
This network shows the impact of papers produced by Ifat Geron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ifat Geron. The network helps show where Ifat Geron may publish in the future.
Co-authors
The 25 scholars most cited alongside Ifat Geron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 183 | |
| 2 | 2009 | 182 | |
| 3 | 2006 | 173 | |
| 4 | 2008 | 104 | |
| 5 | 2009 | 82 | |
| 6 | 2014 | 64 | |
| 7 | 2005 | 55 | |
| 8 | 2008 | 45 | |
| 9 | 2012 | 29 | |
| 10 | 2013 | 29 | |
| 11 | 2010 | 25 | |
| 12 | Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia. A possible etiology for venous disease. | 1996 | 19 |
| 13 | 2003 | 16 | |
| 14 | 2014 | 12 | |
| 15 | 2010 | 12 | |
| 16 | 2007 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2007 | 3 | |
| 19 | 2006 | 2 | |
| 20 | 2006 | 2 |
About Ifat Geron
Ifat Geron is a scholar working on Hematology, Surgery, Molecular Biology, Oncology and Genetics, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Pancreatic function and diabetes (6 papers), Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Diabetes and associated disorders (4 papers), Diabetes Management and Research (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Hematology (230 citations), Genetics (150 citations), Endocrinology, Diabetes and Metabolism (186 citations), Cancer Research (146 citations) and Molecular Biology (591 citations). Ifat Geron has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Pamela Itkin‐Ansari, Ergeng Hao, Fred Levine, Catriona Jamieson, Annelie Abrahamsson, Björn Tyrberg, Mark Mercola, Jeffrey A. Durocher, Charlene F. Barroga and Jason Gotlib. Their work appears in journals such as Blood, Cancer Cell, Nature Medicine, Developmental Dynamics and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.